ETOPOSIDE INJECTION, USP
ETOPOSIDE INJECTION, USP
Discontinued
DIN Number
02241182
Drug Class
Human
Market Date
Dec 28, 1999
Company
HC
hospira healthcare ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02241182
AIG Number0114567002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CB01 ETOPOSIDE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ETOPOSIDEActive
Strength: 20 MG / ML
Monograph: ETOPOSIDE